BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27266285)

  • 1. [Epigenetic and current treatment approaches in chronic obstructive pulmonary disease].
    Duru S
    Tuberk Toraks; 2016 Mar; 64(1):47-52. PubMed ID: 27266285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
    Xu PW; Jin YT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms in chronic obstructive pulmonary disease.
    Zong DD; Ouyang RY; Chen P
    Eur Rev Med Pharmacol Sci; 2015; 19(5):844-56. PubMed ID: 25807439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation in Chronic Obstructive Pulmonary Disease.
    Chen X; Yan F; Lin X; Shi L; Wang X; Zeng Y
    Adv Exp Med Biol; 2020; 1255():83-98. PubMed ID: 32949392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction.
    Barreiro E; Sznajder JI
    J Appl Physiol (1985); 2013 May; 114(9):1263-72. PubMed ID: 23305984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review.
    Zhang L; Valizadeh H; Alipourfard I; Bidares R; Aghebati-Maleki L; Ahmadi M
    COPD; 2020 Jun; 17(3):333-342. PubMed ID: 32558592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in chronic obstructive pulmonary disease.
    Huo X; Jin S; Wang Y; Ma L
    Epigenomics; 2021 Jul; 13(14):1145-1155. PubMed ID: 34142873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics in asthma and COPD.
    Kabesch M; Adcock IM
    Biochimie; 2012 Nov; 94(11):2231-41. PubMed ID: 22874820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
    Schamberger AC; Mise N; Meiners S; Eickelberg O
    Expert Opin Drug Discov; 2014 Jun; 9(6):609-28. PubMed ID: 24850530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of epigenetics in the development of chronic obstructive pulmonary disease.
    Sakao S; Tatsumi K
    Respirology; 2011 Oct; 16(7):1056-63. PubMed ID: 21824218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.
    Barreiro E; Gea J
    Transl Res; 2015 Jan; 165(1):61-73. PubMed ID: 24794953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.
    Saco TV; Breitzig MT; Lockey RF; Kolliputi N
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):299-309. PubMed ID: 29096066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach.
    Wu DD; Song J; Bartel S; Krauss-Etschmann S; Rots MG; Hylkema MN
    Pharmacol Ther; 2018 Feb; 182():1-14. PubMed ID: 28830839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulation by
    Qi H; Liu H; Pullamsetti SS; Günther S; Kuenne C; Atzberger A; Sommer N; Hadzic S; Günther A; Weissmann N; Zhou Y; Yuan X; Braun T
    Circulation; 2021 Sep; 144(13):1042-1058. PubMed ID: 34247492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics.
    Sundar IK; Mullapudi N; Yao H; Spivack SD; Rahman I
    Curr Opin Pulm Med; 2011 Jul; 17(4):279-85. PubMed ID: 21537190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epigenetics: advances of non-coding RNAs regulation in mammalian cells].
    YU H
    Yi Chuan; 2009 Nov; 31(11):1077-86. PubMed ID: 19933087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations in normal and sensitive COPD-diseased human bronchial epithelial cells repeatedly exposed to air pollution-derived PM
    Leclercq B; Platel A; Antherieu S; Alleman LY; Hardy EM; Perdrix E; Grova N; Riffault V; Appenzeller BM; Happillon M; Nesslany F; Coddeville P; Lo-Guidice JM; Garçon G
    Environ Pollut; 2017 Nov; 230():163-177. PubMed ID: 28651088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutriepigenomics and chronic obstructive pulmonary disease: potential role of dietary and epigenetics factors in disease development and management.
    Marín-Hinojosa C; Eraso CC; Sanchez-Lopez V; Hernández LC; Otero-Candelera R; Lopez-Campos JL
    Am J Clin Nutr; 2021 Dec; 114(6):1894-1906. PubMed ID: 34477827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism and chronic obstructive pulmonary disease.
    Yuan C; Chang D; Lu G; Deng X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1385-1393. PubMed ID: 28546746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic targets for novel therapies of lung diseases.
    Comer BS; Ba M; Singer CA; Gerthoffer WT
    Pharmacol Ther; 2015 Mar; 147():91-110. PubMed ID: 25448041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.